Lataa...
Depot medroxyprogesterone acetate administration alters immune markers for HIV preference and increases susceptibility of peripheral CD4(+) T cells to HIV infection
Depot medroxyprogesterone acetate (Depo-Provera) has been associated with an increased risk of HIV acquisition. In a longitudinal study, we investigated the impact of Depo-Provera use by healthy women on expression of immune markers for HIV preference and on HIV infection ex vivo at baseline (visit...
Tallennettuna:
| Julkaisussa: | Immunohorizons |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5703073/ https://ncbi.nlm.nih.gov/pubmed/29188238 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/immunohorizons.1700047 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|